SCHEMBL7688735

SCHEMBL7688735

COc1cc(C)cc(OC)c1-c1csc(-n2c(C)ccc2C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ TSHR P16473 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ ALDH1A1 P00352 5/20 0.37
▸ GAA P10253 4/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ AR P10275 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ RECQL P46063 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ NTSR1 P30989 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MMP14 P50281 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27566803 0.85 MAPT (0.38) MAPTSMN1; SMN2RAB9ANPC1TSHR
SCHEMBL7681878 0.78 ALDH1A1 (0.43) MAPTSMN1; SMN2RAB9ANPC1TSHR
SCHEMBL8894861 0.75 MEN1 (0.54) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL17386575 0.73 MAPT (0.49) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL16644714 0.69 MEN1 (0.50) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL17407189 0.69 MAPT (0.46) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL25256788 0.67 SMN1; SMN2 (0.44) MAPTSMN1; SMN2RAB9ANPC1TSHR
SCHEMBL17407190 0.66 RAB9A (0.45) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL2379547 0.63 ALDH1A1 (0.56) MAPTSMN1; SMN2RAB9ANPC1MEN1
SCHEMBL8896650 0.63 ALDH1A1 (0.63) MAPTSMN1; SMN2RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380230-B1 FOR THERAPY OF DYSKINESIA, OBESITY, IRRITABLE BOWEL SYNDROME, DISEASES WHOSE TREATMENT REQUIRES STIMULATION OF THE CHOLECYSTOKININ CCK-A RECEPTORS SANOFI-SYNTHELABO (FR) 2002-04-30 — — US disclosed
EP-1017693-A1 CARBOXAMIDOTHIAZOLE DERIVATIVES, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI-SYNTHELABO (FR) 2000-07-12 — — EP disclosed
WO-1999015525-A1 CARBOXAMIDOTHIAZOLE DERIVATIVES, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SANOFI-SYNTHELABO (FR) 1999-04-01 — — WO disclosed
Send feedback